Biography
Background & current role
Physician and White House domestic-policy official whom President Trump publicly named on August 19, 2026 as his choice to lead the Food and Drug Administration. Senate confirmation is required before she can serve as FDA commissioner.
Current record notes: {'id': 'overton-fda-choice-2026-08-19', 'date': '2026-08-19', 'display_date': 'August 19, 2026', 'subjects': ['health-vaccines', 'office-role'], 'summary': 'President Trump publicly named Dr. Heidi Overton as his choice to lead the Food and Drug Administration. Reuters and AP report that Senate confirmation is required. This profile keeps the announced choice, formal nomination transmission, Senate action and assumption of office as separate procedural stages.'} {'id': 'overton-dpc-role-2026', 'date': '2026-08-19', 'display_date': 'Current role checked August 19, 2026', 'subjects': ['office-role', 'health-vaccines'], 'summary': 'The U.S. Office of Personnel Management identifies Overton as Deputy Director of the White House Domestic Policy Council. Her earlier White House service includes the 2019–2020 White House Fellows program.'}
FactFlag treats this page as a maintained public-record profile. Specific disputed factual claims are evaluated separately, with the original statement, primary evidence, contextual reporting and any material rebuttal shown together.
Role snapshot
Position & relationship
- Position / relationship
- Deputy Director, White House Domestic Policy Council · Trump-announced FDA nominee
- Affiliation / context
- White House / FDA nominee
- Directory
- White House
- Profile status
- Current White House official; FDA commissioner nomination received by Senate and referred to HELP; confirmation hearing set for September 24, 2026
- Service dates
- White House Domestic Policy Council: current; FDA commissioner: nominee pending Senate confirmation, not yet serving
Role history & transitions
Documented current/future role notes
- President Trump publicly named Dr. Heidi Overton as his choice to lead the Food and Drug Administration. Reuters and AP report that Senate confirmation is required. This profile keeps the announced choice, formal nomination transmission, Senate action and assumption of office as separate procedural stages.
- The U.S. Office of Personnel Management identifies Overton as Deputy Director of the White House Domestic Policy Council. Her earlier White House service includes the 2019–2020 White House Fellows program.
Evidence boundary
Fairness & uncertainty note
This profile distinguishes Overton’s current White House role, Trump’s announced FDA choice, any later formal nomination paperwork, Senate confirmation proceedings, and assumption of office. Criticism or support for her policy views is attributed to the relevant source rather than treated as a factual verdict.
Claims & evidence
Evidence tracker